{
  "docId": "019de070-701b-7388-a208-3e38cd293d9a",
  "docSlug": "f771dd63c4f3642a1d968d8585ded9c7",
  "documentTitle": "Evotec | Investor Day Presentation Deck | 103 slides",
  "authorId": "evotec",
  "authorName": "Evotec",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 103,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "before_after",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide highlights pre-clinical efficacy of iPSC-derived beta cells, noting a transition to Phase I trials.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-701b-7388-a208-3e38cd293d9a/28",
  "deckHref": "/decks/019de070-701b-7388-a208-3e38cd293d9a",
  "deckJsonHref": "/decks/019de070-701b-7388-a208-3e38cd293d9a.json",
  "deckAnchorHref": "/decks/019de070-701b-7388-a208-3e38cd293d9a#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.6,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "chart",
      "text": "Random-fed blood glucose in diabetic mice implanted with GMP iPSC-derived beta cells",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "daf1193f-a560-4425-94bc-13b19c04b2fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.25,
        "x": 0.7,
        "y": 0.3
      },
      "kind": "list",
      "text": "iPSC islet-like clusters deliver long-lasting normoglycemia at human glucose setpoint; Significantly increased resistance to hypoxia; GMP capabilities; Direct efficacy comparison not feasible",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e65ef6c2-3cb5-4ba6-9b06-88df8d5977f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Cells implanted in Theracyte non-oxygenated encapsulation devices; 4000 human donor islet IEQ; Evotec results in agreement with Lee et al., 2009",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3960441c-315d-48f9-bf8e-306c4c236d9b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.82
      },
      "kind": "subtitle",
      "text": "Late pre-clinical development; Phase I expected in 2021/22",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e2697ba-2133-410e-af25-4269cdc8a8cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.25,
        "y": 0.1
      },
      "kind": "title",
      "text": "Durable normalisation of blood glucose levels",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6aa94430-6eed-411c-a7a8-f3548e254b0e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "02307443-ba4e-4297-af02-d2f0bd08a568",
      "evidence": "The slide shows a 'before' scenario of diabetic animal models and an 'after' scenario with iPSC-derived islet-like clusters demonstrating long-lasting normoglycemia.",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "2c0f80a3-38ba-4235-a30b-361b681a8054",
      "evidence": "Comparison of control vs treatment group over time",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 30,
      "from": 15,
      "beatId": "bff745b7-4060-47df-8173-1e462b2c6fda",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The deck provides evidence of Evotec's strategy delivering growth and value potential.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}